GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a significant focus in healthcare investigation, largely due to its impressive impact on controlling conditions such as second type diabetes and obesity. New research have demonstrated that in addition more info to glucose regulation, GLP-1 agonists offer promise for heart